OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
025557

Lung Kee Group Holdings Ltd

Industrial Machinery & EquipmentVerified

Lung Kee Group Holdings Ltd has a current ratio of 6.13, indicating strong short-term liquidity, but its free cash flow is negative at -68.18 million HKD, suggesting operational cash generation is insufficient to cover capital expenditures. The company's debt-to-equity ratio is 0.0, reflecting a conservative capital structure with no long-term debt obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's profitability metrics are weak, with a return on equity of -1.46% and a return on assets of -1.24%, both significantly below the industry median for Industrial Machinery & Equipment firms. Operating income is negative at -33.15 million HKD, and net income is also negative at -22.62 million HKD, indicating operational inefficiencies or declining demand. Lung Kee Group Holdings Ltd operates in a single disclosed segment focused on mould bases and related products, with geographic exposure to China, America, and Europe. Revenue concentration data is not available, but the company's operations are likely diversified across these regions. The absence of segment-specific revenue breakdowns limits visibility into regional performance. The company's growth trajectory is uncertain, with no outlook data provided for the current or next fiscal year. Historical revenue of 1.32 billion HKD is flat compared to prior periods, and the negative operating and net income suggest a lack of growth momentum. The company's capital expenditures of -40.03 million HKD indicate ongoing investment in operations, but the negative free cash flow suggests these investments are not yet generating returns. Risk factors include medium liquidity risk due to negative free cash flow and a negative net cash position, despite a strong current ratio. Dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. The company's financial leverage is minimal, but its profitability challenges and cash flow constraints could increase risk exposure in a downturn. Recent events include the company's reclassification as an investment holding company and its continued focus on the manufacturing and marketing of mould bases. No recent filings or transcripts are available to provide additional insight into strategic direction or operational changes.

30-day price · 0255+0.10 (+6.8%)
Low$1.47High$1.62Close$1.58As of11 May, 00:00 UTC
Profile
CompanyLung Kee Group Holdings Ltd
Ticker0255.HK
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. Lung Kee Group Holdings Ltd is an investment holding company primarily engaged in the manufacturing and marketing of mould bases and related products, with operations in China, America, and Europe.

Classification. Lung Kee Group Holdings Ltd is classified under the Industrial Machinery & Equipment industry within the Industrial Goods business sector, with a confidence level of 0.92.

Lung Kee Group Holdings Ltd has a current ratio of 6.13, indicating strong short-term liquidity, but its free cash flow is negative at -68.18 million HKD, suggesting operational cash generation is insufficient to cover capital expenditures. The company's debt-to-equity ratio is 0.0, reflecting a conservative capital structure with no long-term debt obligations. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's profitability metrics are weak, with a return on equity of -1.46% and a return on assets of -1.24%, both significantly below the industry median for Industrial Machinery & Equipment firms. Operating income is negative at -33.15 million HKD, and net income is also negative at -22.62 million HKD, indicating operational inefficiencies or declining demand. Lung Kee Group Holdings Ltd operates in a single disclosed segment focused on mould bases and related products, with geographic exposure to China, America, and Europe. Revenue concentration data is not available, but the company's operations are likely diversified across these regions. The absence of segment-specific revenue breakdowns limits visibility into regional performance. The company's growth trajectory is uncertain, with no outlook data provided for the current or next fiscal year. Historical revenue of 1.32 billion HKD is flat compared to prior periods, and the negative operating and net income suggest a lack of growth momentum. The company's capital expenditures of -40.03 million HKD indicate ongoing investment in operations, but the negative free cash flow suggests these investments are not yet generating returns. Risk factors include medium liquidity risk due to negative free cash flow and a negative net cash position, despite a strong current ratio. Dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. The company's financial leverage is minimal, but its profitability challenges and cash flow constraints could increase risk exposure in a downturn. Recent events include the company's reclassification as an investment holding company and its continued focus on the manufacturing and marketing of mould bases. No recent filings or transcripts are available to provide additional insight into strategic direction or operational changes.
Key takeaways
  • Lung Kee Group Holdings Ltd has a strong current ratio but negative free cash flow, indicating liquidity is not being effectively converted into growth.
  • The company's return on equity and return on assets are negative, significantly below industry medians, signaling poor profitability.
  • The company operates in a single segment with geographic exposure to China, America, and Europe, but lacks detailed revenue concentration data.
  • Growth is uncertain, with flat revenue and negative operating and net income.
  • Liquidity risk is medium, and dilution risk is low, but profitability challenges persist.
  • No recent strategic or operational events have been disclosed to suggest a turnaround.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$1.32B
Gross profit$848.1M
Operating income-$33.1M
Net income-$22.6M
R&D
SG&A
D&A
SBC
Operating cash flow$208.1M
CapEx-$40.0M
Free cash flow-$68.2M
Total assets$1.82B
Total liabilities$266.9M
Total equity$1.55B
Cash & equivalents
Long-term debt$4.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.55B
Net cash-$4.4M
Current ratio6.1
Debt/Equity0.0
ROA-1.2%
ROE-1.5%
Cash conversion-9.2%
CapEx/Revenue-3.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
Metric0255Activity
Op margin-2.5%9.4% medp25 9.4% · p75 9.4%bottom quartile
Net margin-1.7%5.8% medp25 5.8% · p75 5.8%bottom quartile
Gross margin64.3%26.9% medp25 26.9% · p75 26.9%top quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-3.0%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity0.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 13:42 UTC#33c4e407
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 13:44 UTCJob: 632b4e6b